Claudin-1 enhances tumor proliferation and metastasis by regulating cell anoikis in gastric cancer

Jie Huang; Li Zhang; Changyu He; Ying Qu; Jianfang Li; Jianian Zhang; Tao Du; Xuehua Chen; Yingyan Yu; Bingya Liu; Zhenggang Zhu

doi:10.18632/oncotarget.2936

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Claudin-1 enhances tumor proliferation and metastasis by regulating cell anoikis in gastric cancer

Jie Huang, Li Zhang, Changyu He, Ying Qu, Jianfang Li, Jianian Zhang, Tao Du, Xuehua Chen, Yingyan Yu, Bingya Liu _ and Zhenggang Zhu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:1652-1665. https://doi.org/10.18632/oncotarget.2936

Metrics: PDF 3048 views | HTML 3362 views | ?

Abstract

Jie Huang1, Li Zhang1, Changyu He1, Ying Qu1, Jianfang Li1, Jianian Zhang1, Tao Du1, Xuehua Chen1, Yingyan Yu1, Bingya Liu1 and Zhenggang Zhu1

1 Shanghai Key Laboratory of Gastric Neoplasms, Department of Surgery, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Correspondence:

Bingya Liu, email:

Zhenggang Zhu, email:

Keywords: Claudin-1, Anoikis, β-catenin, Gastric cancer

Received: August 14, 2014 Accepted: December 01, 2014 Published: December 02, 2014

Abstract

Claudin-1 (CLDN1) is overexpressed in gastric cancer and correlated with tumor invasion, metastasis and poor outcome. Here, we both down and up regulated CLDN1 expression in gastric cancer cells to elucidate its role in gastric carcinogenesis and tumor progression. We found that deficiency of CLDN1 inhibited cells migration, invasion, and colony formation in vitro and tumorigenicity, metastasis in vivo. Also, CLDN1 promoted cell aggregation and increased anoikis resistance. Down or up regulation of CLDN1 was accompanied with changes of membrane β-catenin expression as well as Akt and Src activities. When β-catenin was up-regulated in CLDN1-KD cells, cell aggregation and anoikis resistance were restored, and Akt and Src signal pathways were re-activated. Taken together, these findings suggest that CLDN1 is oncogenic in gastric cancer and its malignant potential may be attributed in part to regulation of anoikis, by mediating membrane β-catenin-regulated cell-cell adhesion and cell survival.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2936

Publication Alerts

Research Papers:

Claudin-1 enhances tumor proliferation and metastasis by regulating cell anoikis in gastric cancer

Abstract